FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lutz Schmidt

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
R Schennach; M Schmauss; Lutz G Schmidt; Florian Seemüller; E Rüther; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; S Klingberg; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; S Meyer; Hans-Jürgen Möller; D Naber; H Pfeiffer; Michael Riedel
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Richard Musil; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lutz Schmidt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: R Schennach; M Schmauss; Lutz G Schmidt; Florian Seemüller; E Rüther; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; S Klingberg; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; S Meyer; Hans-Jürgen Möller; D Naber; H Pfeiffer; Michael Riedel
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(8):625-33.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Richard Musil; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
Schizophrenia research 2012;139(1-3):218-24.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.
The Psychiatric quarterly 2012;83(2):187-207.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
Psychopathology 2012;45(5):276-85.
2011: Rebecca Schennach-Wolff; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Journal of psychiatric research 2011;45(12):1639-47.
2011: R Schennach-Wolff; Lutz G Schmidt; Florian Seemüller; E Rüther; Gerhard Buchkremer; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; T Messer; Hans-Jürgen Möller; D Naber; M Obermeier; H Pfeiffer; Michael Riedel
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(5):284-92.
2011: R Schennach-Wolff; M Obermeier; Florian Seemüller; Markus Jäger; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Acta psychiatrica Scandinavica 2011;123(3):228-38.
2010: Rebecca Schennach-Wolff; Michael Obermeier; Florian Seemüller; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Rolf R Engel; Hans-Jürgen Möller; Michael Riedel
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Journal of clinical psychopharmacology 2010;30(6):726-31.
2010: R Schennach-Wolff; Hans-Jürgen Möller; Markus Jäger; Florian Seemüller; M Obermeier; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Michael Riedel
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Pharmacopsychiatry 2010;43(7):245-51.
2010: Jörn Reese; Adrian Kraschewski; Ion Anghelescu; Georg Winterer; Lutz G Schmidt; Jürgen Gallinat; Franz Rüschendorf; Hans Rommelspacher; Catrin Wernicke
Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics.
Psychiatric genetics 2010;20(4):140-52.
2010: Rebecca Schennach-Wolff; Markus Jäger; Michael Obermeier; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(5):729-38.
2010: Markus Jäger; Michael Riedel; M Obermeier; R Schennach-Wolff; Florian Seemüller; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; K-U Kühn; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Ronald Bottlender; Hans-Jürgen Möller
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
Schizophrenia research 2010;118(1-3):183-8.
2010: R Schennach-Wolff; Markus Jäger; Florian Seemüller; M Obermeier; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Acta psychiatrica Scandinavica 2010;121(5):359-70.
2009: Markus Jäger; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; D Degner; Gerhard Buchkremer; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(8):501-6.
2009: Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Attitude towards adherence in patients with schizophrenia at discharge.
Journal of psychiatric research 2009;43(16):1294-301.
2009: Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Wolfgang Huff; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
Schizophrenia research 2009;113(2-3):210-7.
2009: Adrian Kraschewski; Jörn Reese; Ion Anghelescu; Georg Winterer; Lutz G Schmidt; Jürgen Gallinat; Ulrich Finckh; Hans Rommelspacher; Catrin Wernicke
Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function.
Pharmacogenetics and genomics 2009;19(7):513-27.
2009: Andreas Fellgiebel; Elzbieta Kojro; Matthias J Müller; Armin Scheurich; Lutz G Schmidt; Falk Fahrenholz
CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
Journal of geriatric psychiatry and neurology 2009;22(1):3-9.
2009: Markus Jäger; Michael Riedel; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerd Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Prediction of symptom remission in schizophrenia during inpatient treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):426-34.
2008: Markus Jäger; T Messer; G Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Michael Riedel; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
Pharmacopsychiatry 2008;41(5):190-5.
2008: Michael Linden; Anja Westram; Lutz G Schmidt; Clemenz Haag
Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.
European psychiatry : the journal of the Association of European Psychiatrists 2008;23(6):403-8.
2008: Markus Jäger; Michael Riedel; Max Schmauss; Herbert Pfeiffer; Gerd Laux; Dieter Naber; Wolfgang Gaebel; Wolfgang Huff; Lutz G Schmidt; Isabella Heuser; Gerhard Buchkremer; Kai-Uwe Kühn; Eckart Rüther; Paul Hoff; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Psychiatry research 2008;158(3):297-305.
2008: Christoph Fehr; Igor Yakushev; Nina Hohmann; Hans-Georg Buchholz; Christian Landvogt; Hanna Deckers; Alexandra Eberhardt; Marie Kläger; Michael N Smolka; Armin Scheurich; Thomas Dielentheis; Lutz G Schmidt; Frank Rösch; Peter Bartenstein; Gerhard Gründer; Mathias Schreckenberger
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
The American journal of psychiatry 2008;165(4):507-14.
2007: Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Wölwer; Ansgar Klimke; Matthias Eickhoff; Martina Von Wilmsdorff; Maria C Jockers-Scherübl; Kai-Uwe Kühn; Matthias Lemke; Andreas Bechdolf; Stefan Bender; Detlef Degner; Ralf Schlösser; Lutz G Schmidt; Andrea Schmitt; Markus Jäger; Gerhard Buchkremer; Peter Falkai; Stefan Klingberg; Wolfgang Köpcke; Wolfgang Maier; Heinz Häfner; Christian Ohmann; Hans Joachim Salize; Frank Schneider; Hans-Jürgen Möller
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
The Journal of clinical psychiatry 2007;68(11):1763-74.
2007: Maria C Jockers-Scherübl; Armin Bauer; Silke Kuhn; Friedel M Reischies; Heidi Danker-Hopfe; Lutz G Schmidt; Johannes Rentzsch; Rainer Hellweg
Nerve growth factor in serum is a marker of the stage of alcohol disease.
Neuroscience letters 2007;419(1):78-82.
2007: Lutz G Schmidt; Michael N Smolka
Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers.
Alcohol and alcoholism (Oxford, Oxfordshire) 2007;42(3):241-6.
2007: Markus Jäger; Michael Riedel; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Wolfgang Huff; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
European archives of psychiatry and clinical neuroscience 2007;257(1):47-53.
2007: Henning Budde; Ulrich Zimmermann; Birgit Steffin; Hans Rommelspacher; Lutz G Schmidt; Michael N Smolka
Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
Alcoholism, clinical and experimental research 2007;31(1):100-3.
2006: Lutz G Schmidt
[Substance-induced disorders: moving towards DSM-V and ICD-11].
Fortschritte der Neurologie-Psychiatrie 2006;74(11):634-42.
2006: Joachim Schüz; Christian Petters; Ulrich T Egle; Bernd Jansen; Renate Kimbel; Stephan Letzel; Wilfred Nix; Lutz G Schmidt; Lutz Vollrath
The "Mainzer EMF-Wachhund": results from a watchdog project on self-reported health complaints attributed to exposure to electromagnetic fields.
Bioelectromagnetics 2006;27(4):280-7.
2006: Klaus Mann; Christoph Hiemke; Lutz G Schmidt; David Bates
Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care.
Therapeutic drug monitoring 2006;28(1):83-8.
2006: Christoph Fehr; Thomas Sander; André Tadic; Kirsten P Lenzen; Ion Anghelescu; Christoph Klawe; Norbert Dahmen; Lutz G Schmidt; Armin Szegedi
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.
Psychiatric genetics 2006;16(1):9-17.
2006: Karl Mann; Klaus Ackermann; Alexander Diehl; D Ebert; Götz Mundle; Helmut Nakovics; T Reker; G Richter; Lutz G Schmidt; M Driessen; K Rettig; K Opitz; Bernhard Croissant
Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial.
Psychopharmacology 2006;184(1):115-21.
2005: Matthias J Müller; Kay-Maria Müller; A Dascalescu; Catharina Whybra; Karin Baron; Armin Scheurich; K Mann; Michael Beck; Lutz G Schmidt; Andreas Fellgiebel
[Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Fortschritte der Neurologie-Psychiatrie 2005;73(11):687-93.
2005: Andreas Fellgiebel; Matthias J Müller; Paulo R Wille; Paulo R Dellani; Armin Scheurich; Lutz G Schmidt; Peter Stoeter
Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.
Neurobiology of aging 2005;26(8):1193-8.
2005: Lutz G Schmidt; S Bleich; Jobst Boening; G Buehringer; J Kornhuber; Heinz-Gerd Weijers; Gerhard A Wiesbeck; J Wolfgramm; Ursula Havemann-Reinecke
Advances in alcoholism research in Germany.
Alcoholism, clinical and experimental research 2005;29(7):1282-7.
2005: Armin Scheurich; Matthias J Muller; Thomas Siessmeier; Peter Bartenstein; Lutz G Schmidt; Andreas Fellgiebel
Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic.
Dementia and geriatric cognitive disorders 2005;20(5):271-7.
2004: Michael N Smolka; Henning Budde; Anne C Karow; Lutz G Schmidt
Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence.
Psychopharmacology 2004;175(3):374-81.
2004: Andreas Fellgiebel; Thomas Siessmeier; Armin Scheurich; Georg Winterer; Peter Bartenstein; Lutz G Schmidt; Matthias J Müller
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.
Biological psychiatry 2004;56(4):279-83.
2004: Lutz G Schmidt
[Helping smokers kick the habit].
MMW Fortschritte der Medizin 2004;146(17):34, 36, 38-9.
2004: Detlef Degner; Renate Grohmann; Stefan Kropp; Eckart Rüther; Stefan Bender; Rolf R Engel; Lutz G Schmidt
Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.
Pharmacopsychiatry 2004;37 Suppl 1():S39-45.
2004: Renate Grohmann; H Hippius; H Helmchen; Eckart Rüther; Lutz G Schmidt
The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Pharmacopsychiatry 2004;37 Suppl 1():S16-26.
2004: Andreas Fellgiebel; Thomas Siessmeier; Georg Winterer; Hartmut Lüddens; Klaus Mann; Lutz G Schmidt; Peter Bartenstein
Increased cerebellar PET glucose metabolism corresponds to ataxia in Wernicke-Korsakoff syndrome.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(2):150-3.
2004: Andreas Fellgiebel; Paulo R Wille; Matthias J Müller; Georg Winterer; Armin Scheurich; Goran Vucurevic; Lutz G Schmidt; Peter Stoeter
Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Dementia and geriatric cognitive disorders 2004;18(1):101-8.
2003: Catrin Wernicke; Jerzy Samochowiec; Lutz G Schmidt; Georg Winterer; Michael N Smolka; Jolanta Kucharska-Mazur; Jan Horodnicki; Jürgen Gallinat; Hans Rommelspacher
Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits.
Biological psychiatry 2003;54(9):922-8.
2003: Andreas Fellgiebel; Armin Scheurich; Thomas Siessmeier; Lutz G Schmidt; Peter Bartenstein
Persistence of disturbed thalamic glucose metabolism in a case of Wernicke-Korsakoff syndrome.
Psychiatry research 2003;124(2):105-12.
2003: Lutz G Schmidt
[Early diagnosis of alcohol abuse and alcohol dependence in general practice].
MMW Fortschritte der Medizin 2003;145 Suppl 2():31-4, 36.
2003: Georg Winterer; Richard Mahlberg; Michael N Smolka; Jerzy Samochowiec; Mario Ziller; Hans Rommelspacher; Werner M Herrmann; Lutz G Schmidt; Thomas Sander
Association analysis of exonic variants of the GABA(B)-receptor gene and alpha electroencephalogram voltage in normal subjects and alcohol-dependent patients.
Behavior genetics 2003;33(1):7-15.
2002: Catrin Wernicke; Michael N Smolka; Jürgen Gallinat; Georg Winterer; Lutz G Schmidt; Hans Rommelspacher
Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population.
Neuroscience letters 2002;333(1):45-8.
2002: Verena Eggers; Joke Tio; Tim Neumann; Fritz Pragst; Christian Müller; Lutz G Schmidt; Wolfgang J Kox; Claudia D Spies
Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit.
Intensive care medicine 2002;28(10):1475-82.
2002: Jerzy Samochowiec; Jolanta Kucharska-Mazur; Filip Rybakowski; Agata Ostapowicz; Jan Horodnicki; M Rozpara; R Kamiński; A Skrzypińska; G Arentowicz; Hans Rommelspacher; Lutz G Schmidt
Norepinephrine transporter polymorphism and personality trait of reward dependence in male alcoholics.
Pharmacopsychiatry 2002;35(5):195-6.
2002: Jerzy Samochowiec; Jolanta Kucharska-Mazur; Ryszard Kaminski; Michael N Smolka; Hans Rommelschpacher; Catrin Wernicke; Agnieszka Tymicz; Lutz G Schmidt
Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence.
Psychiatry research 2002;111(2-3):229-33.
2002: Lutz G Schmidt; Götz Mundle; Markus Banger; Friedhelm Stetter; Michael Soyka; Clemens Veltrup; Karl Mann
[The qualified-detoxification-of-alcoholics procedure--in light of the development of guidelines for the treatment of substance-related disorders].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2002;96(5):295-300.
2002: Lutz G Schmidt; Jerzy Samochowiec; Ulrich Finckh; Ewa Fiszer-Piosik; Jan Horodnicki; Birgit Wendel; Hans Rommelspacher; Margret R Hoehe
Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence.
Drug and alcohol dependence 2002;65(3):221-4.
2002: Lutz G Schmidt; Silke Kuhn; Michael N Smolka; Kai Schmidt; Hans Rommelspacher
Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(2):209-17.
2001: Lutz G Schmidt
[Alcohol drinking at the threshold of abuse. When is it really critical?].
MMW Fortschritte der Medizin 2001;143(23):20-2.
2001: Hans Rommelspacher; Michael N Smolka; Lutz G Schmidt; Jerzy Samochowiec; Margret R Hoehe
Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals.
Alcohol (Fayetteville, N.Y.) 2001;24(2):129-35.
2001: Lutz G Schmidt; Michael N Smolka
Relapse prevention in alcoholics by cigarette smoking? Involvement of nicotinic-dopaminergic mechanisms.
Alcohol (Fayetteville, N.Y.) 2001;24(2):111-5.
2001: I Matsumoto; P A Wilce; T Buckley; P Dodd; J Puzke; R Spanagel; W Zieglgansberger; G Wolf; S Leng; Hans Rommelspacher; Ulrich Finckh; Lutz G Schmidt
Ethanol and gene expression in brain.
Alcoholism, clinical and experimental research 2001;25(5 Suppl ISBRA):82S-86S.
2001: K Schmidt; B Nolte-Zenker; J Patzer; Michael Bauer; Lutz G Schmidt; A Heinz
Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
Pharmacopsychiatry 2001;34(2):66-72.
2000: Thomas Sander; Agata Ostapowicz; Jerzy Samochowiec; Michael N Smolka; Georg Winterer; Lutz G Schmidt
Genetic variation of the glutamate transporter EAAT2 gene and vulnerability to alcohol dependence.
Psychiatric genetics 2000;10(3):103-7.
2000: Jerzy Samochowiec; M Ladehoff; J Pelz; Michael N Smolka; Lutz G Schmidt; Hans Rommelspacher; Ulrich Finckh
Predominant influence of the 3'-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics.
Pharmacogenetics 2000;10(5):471-5.
2000: Lutz G Schmidt; P Dufeu; S Kuhn; M Smolka; Hans Rommelspacher
Transition to alcohol dependence: clinical and neurobiological considerations.
Comprehensive psychiatry 2000;41(2 Suppl 1):90-4.
2000: N Gscheidel; Thomas Sander; Birgit Wendel; Petra Heere; Lutz G Schmidt; Hans Rommelspacher; Margret R Hoehe; Jerzy Samochowiec
Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence.
Polish journal of pharmacology 2000;52(1):27-31.
2000: Lutz G Schmidt; Thomas Sander; S Kuhn; Michael N Smolka; Hans Rommelspacher; Jerzy Samochowiec; Klaus-Peter Lesch
Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(6):681-9.
1999: M Smolka; Lutz G Schmidt
The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
Addiction (Abingdon, England) 1999;94(8):1191-8.
1999: Michael N Smolka; Thomas Sander; Lutz G Schmidt; Jerzy Samochowiec; Hans Rommelspacher; N Gscheidel; Birgit Wendel; Margret R Hoehe
mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal.
Psychoneuroendocrinology 1999;24(6):629-38.
1999: Jerzy Samochowiec; M Rottmann; Olga Okladnova; Yana V Syagailo; Gerald Stöber; Thomas Sander; E Mühlbauer; Michael N Smolka; M Tranitz; Georg Winterer; Hans Rommelspacher; Lutz G Schmidt; Klaus-Peter Lesch
Association analysis of a PAX-6 gene promoter-associated polymorphic repeat with alcohol dependence.
Addiction biology 1999;4(3):323-8.
1999: Thomas Sander; Jerzy Samochowiec; M Ladehoff; Michael N Smolka; C Peters; Olaf Riess; Hans Rommelspacher; Lutz G Schmidt
Association analysis of exonic variants of the gene encoding the GABAB receptor and alcohol dependence.
Psychiatric genetics 1999;9(2):69-73.
1999: Jerzy Samochowiec; Klaus-Peter Lesch; M Rottmann; Michael N Smolka; Yana V Syagailo; Olga Okladnova; Hans Rommelspacher; Georg Winterer; Lutz G Schmidt; Thomas Sander
Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism.
Psychiatry research 1999;86(1):67-72.
1999: Jerzy Samochowiec; Michael N Smolka; Georg Winterer; Hans Rommelspacher; Lutz G Schmidt; Thomas Sander
Association analysis between a Cys23Ser substitution polymorphism of the human 5-HT2c receptor gene and neuronal hyperexcitability.
American journal of medical genetics 1999;88(2):126-30.
1999: Thomas Sander; M Ladehoff; Jerzy Samochowiec; Ulrich Finckh; Hans Rommelspacher; Lutz G Schmidt
Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population.
Alcoholism, clinical and experimental research 1999;23(4):578-81.
1999: Thomas Sander; D Ball; R Murray; J Patel; Jerzy Samochowiec; Georg Winterer; Hans Rommelspacher; Lutz G Schmidt; E W Loh
Association analysis of sequence variants of GABA(A) alpha6, beta2, and gamma2 gene cluster and alcohol dependence.
Alcoholism, clinical and experimental research 1999;23(3):427-31.
1998: Thomas Sander; N Gscheidel; Birgit Wendel; Jerzy Samochowiec; Michael N Smolka; Hans Rommelspacher; Lutz G Schmidt; Margret R Hoehe
Human mu-opioid receptor variation and alcohol dependence.
Alcoholism, clinical and experimental research 1998;22(9):2108-10.
1998: Thomas Sander; H Harms; P Dufeu; S Kuhn; Margret R Hoehe; Klaus-Peter Lesch; Hans Rommelspacher; Lutz G Schmidt
Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder.
Biological psychiatry 1998;43(12):908-12.
1998: Lutz G Schmidt; H Harms; S Kuhn; Hans Rommelspacher; Thomas Sander
Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene.
The American journal of psychiatry 1998;155(4):474-8.
1998: Georg Winterer; B Klöppel; A Heinz; Mario Ziller; P Dufeu; Lutz G Schmidt; Werner M Herrmann
Quantitative EEG (QEEG) predicts relapse in patients with chronic alcoholism and points to a frontally pronounced cerebral disturbance.
Psychiatry research 1998;78(1-2):101-13.
1998: Thomas Sander; H Harms; Hans Rommelspacher; Margret R Hoehe; Lutz G Schmidt
Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium.
Psychiatric genetics 1998;8(1):13-7.
1998: Georg Winterer; Mario Ziller; B Klöppel; A Heinz; Lutz G Schmidt; Werner M Herrmann
Analysis of quantitative EEG with artificial neural networks and discriminant analysis--a methodological comparison.
Neuropsychobiology 1998;37(1):41-8.
1997: Thomas Sander; H Harms; Klaus-Peter Lesch; P Dufeu; S Kuhn; Margret R Hoehe; Hans Rommelspacher; Lutz G Schmidt
Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence.
Alcoholism, clinical and experimental research 1997;21(8):1356-9.
1997: Lutz G Schmidt; P Dufeu; A Heinz; S Kuhn; Hans Rommelspacher
Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content.
Psychiatry research 1997;72(3):177-85.
1997: Thomas Sander; H Harms; P Dufeu; S Kuhn; Hans Rommelspacher; Lutz G Schmidt
Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics.
American journal of medical genetics 1997;74(5):483-7.
1997: Jerzy Samochowiec; Z Kleinrok; E Jagiełło-Wójtowicz; Jan Horodnicki; Hans Rommelspacher; Lutz G Schmidt
Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
Polish journal of pharmacology 1997;49(4):221-7.
1997: Ulrich Finckh; Hans Rommelspacher; S Kuhn; P Dufeu; G Otto; A Heinz; Michael Dettling; M Giraldo-Velasquez; J Pelz; KJ Gräf; H Harms; Thomas Sander; Lutz G Schmidt; A Rolfs
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism.
Pharmacogenetics 1997;7(4):271-81.
1997: Thomas Sander; H Harms; J Podschus; Ulrich Finckh; B Nickel; A Rolfs; Hans Rommelspacher; Lutz G Schmidt
Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium.
Biological psychiatry 1997;41(3):299-304.
1997: Lutz G Schmidt; K Schmidt; P Dufeu; A Ohse; Hans Rommelspacher; C Müller
Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism.
The American journal of psychiatry 1997;154(1):75-80.
1996: A Heinz; P Dufeu; S Kuhn; Michael Dettling; KJ Gräf; I Kürten; Hans Rommelspacher; Lutz G Schmidt
Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients.
Archives of general psychiatry 1996;53(12):1123-8.
1996: Hans Rommelspacher; M Wiest; Ruth Neuhaus; W Platzgummer; Lutz G Schmidt; Peter Neuhaus
Long-term changes of markers of alcoholism after orthotopic liver transplantation (OLT).
Transplantation 1996;62(10):1451-5.
1996: Ulrich Finckh; M Giraldo-Velasquez; J Pelz; G Otto; Thomas Sander; Lutz G Schmidt; Hans Rommelspacher; A Rolfs
Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians.
Gene 1996;179(2):251-5.
1996: P Dufeu; J Podschus; Lutz G Schmidt
[Alcohol dependence in homeless men. Incidence, development and determinants].
Der Nervenarzt 1996;67(11):930-4.
1996: A Heinz; Thomas Sander; H Harms; Ulrich Finckh; S Kuhn; P Dufeu; Michael Dettling; KJ Gräf; A Rolfs; Hans Rommelspacher; Lutz G Schmidt
Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism.
Alcoholism, clinical and experimental research 1996;20(6):1109-13.
1996: A Heinz; K Schmidt; S S Baum; S Kuhn; P Dufeu; Lutz G Schmidt; Hans Rommelspacher
Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism.
Journal of studies on alcohol 1996;57(5):471-4.
1996: Victor Perez; Georg Juckel; Lutz G Schmidt; Hans Rommelspacher
Serotonergic ethanol effects and auditory evoked dipole activity in alcoholic and healthy subjects.
Psychiatry research 1996;63(1):47-55.
1996: A Heinz; M Bauer; S Kuhn; F Krüger; KJ Gräf; Hans Rommelspacher; Lutz G Schmidt
Long-term observation of the hypothalamic-pituitary-thyroid (HPT) axis in alcohol-dependent patients.
Acta psychiatrica Scandinavica 1996;93(6):470-6.
1996: Ulrich Finckh; O von Widdern; M Giraldo-Velasquez; J Podschus; P Dufeu; Thomas Sander; H Harms; Lutz G Schmidt; Hans Rommelspacher; A Rolfs
No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism.
Alcoholism, clinical and experimental research 1996;20(3):528-32.
1996: Lutz G Schmidt; Michael Dettling; K J Graef; A Heinz; S Kuhn; J Podschus; Hans Rommelspacher
Reduced dopaminergic function in alcoholics is related to severe dependence.
Biological psychiatry 1996;39(3):193-8.
1996: Hans Rommelspacher; P Dufeu; Lutz G Schmidt
Harman and norharman in alcoholism: correlations with psychopathology and long-term changes.
Alcoholism, clinical and experimental research 1996;20(1):3-8.
1995: Michael Dettling; A Heinz; P Dufeu; Hans Rommelspacher; KJ Gräf; Lutz G Schmidt
Dopaminergic responsivity in alcoholism: trait, state, or residual marker?
The American journal of psychiatry 1995;152(9):1317-21.
1995: A Heinz; Lutz G Schmidt; Georg Winterer; L Gerhard; H Przuntek
[Optical and tactile hallucinosis as clinical onset of Creutzfeld-Jakob disease].
Der Nervenarzt 1995;66(9):712-6.
1995: B Lichtenberg-Kraag; T May; Lutz G Schmidt; Hans Rommelspacher
Changes of G-protein levels in platelet membranes from alcoholics during short-term and long-term abstinence.
Alcohol and alcoholism (Oxford, Oxfordshire) 1995;30(4):455-64.
1995: Hans Rommelspacher; S Sllström Baum; P Dufeu; Lutz G Schmidt
Determination of (R)- and (S)-salsolinol sulfate and dopamine sulfate levels in plasma of nonalcoholics and alcoholics.
Alcohol (Fayetteville, N.Y.) 1995;12(4):309-15.
1995: Lutz G Schmidt; P Dufeu; S Kuhn; Hans Rommelspacher
[Current aspects of pharmacotherapy of alcoholism].
Der Nervenarzt 1995;66(5):323-30.
1995: Georg Juckel; Lutz G Schmidt; Hans Rommelspacher; Victor Perez
The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity.
Biological psychiatry 1995;37(5):311-7.
1995: Victor Perez; K Lipperheide; Georg Juckel; Lutz G Schmidt; Hans Rommelspacher
Antisocial tendencies and cortical sensory-evoked responses in alcoholism.
Alcoholism, clinical and experimental research 1995;19(1):31-6.
1995: Thomas Sander; H Harms; J Podschus; Ulrich Finckh; B Nickel; A Rolfs; Hans Rommelspacher; Lutz G Schmidt
Dopamine D1, D2 and D3 receptor genes in alcohol dependence.
Psychiatric genetics 1995;5(4):171-6.
1994: Hans Rommelspacher; T May; P Dufeu; Lutz G Schmidt
Longitudinal observations of monoamine oxidase B in alcoholics: differentiation of marker characteristics.
Alcoholism, clinical and experimental research 1994;18(6):1322-9.
1994: Georg Winterer; Lutz G Schmidt; K Frick; G Ulrich
["Neuroadaptation" in long-term cannabis abuse. A clinical and electroencephalographic case study].
Der Nervenarzt 1994;65(9):635-7.
1994: A Heinz; Lutz G Schmidt; Friedel M Reischies
Anhedonia in schizophrenic, depressed, or alcohol-dependent patients--neurobiological correlates.
Pharmacopsychiatry 1994;27 Suppl 1():7-10.
1994: Lutz G Schmidt; P Dufeu; S Kuhn; Hans Rommelspacher
Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study.
Pharmacopsychiatry 1994;27 Suppl 1():21-3.
1994: Lutz G Schmidt
Neurobiology of psychotropic drugs: modes of action and therapeutic efficacy.
Pharmacopsychiatry 1994;27 Suppl 1():2-3.
1994: T Sander; Lutz G Schmidt
Molecular biological perspectives in treating neuropsychiatric disorders with dopaminergic drugs.
Pharmacopsychiatry 1994;27 Suppl 1():11-4.
1994: Andreas Baumgartner; Hans Rommelspacher; M Otto; Lutz G Schmidt; I Kürten; KJ Gräf; Angel Campos-Barros; W Platz
Hypothalamic-pituitary-thyroid (HPT) axis in chronic alcoholism. I. HPT axis in chronic alcoholics during withdrawal and after 3 weeks of abstinence.
Alcoholism, clinical and experimental research 1994;18(2):284-94.
1994: Georg Juckel; A Frota; Jürgen Gallinat; Lutz G Schmidt; Hans Rommelspacher; Victor Perez
Auditory-evoked dipole source activity as indicator of withdrawal severity in alcoholic patients.
Pharmacopsychiatry 1994;27(2):79-81.
1993: Renate Grohmann; C Ströbel; Eckart Rüther; P Dirschedl; H Helmchen; H Hippius; Bruno Müller-Oerlinghausen; Lutz G Schmidt; B Wolf
Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
Pharmacopsychiatry 1993;26(3):84-93.
1993: Lutz G Schmidt; P Dufeu; Hans Rommelspacher
[Diagnosis of alcohol dependence].
Der Nervenarzt 1993;64(1):36-43.
1991: Hans Rommelspacher; Lutz G Schmidt; H Helmchen
[Pathobiochemistry and pharmacotherapy of alcohol withdrawal delirium].
Der Nervenarzt 1991;62(11):649-57.
1991: Hans Rommelspacher; Lutz G Schmidt; T May
Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics.
Alcoholism, clinical and experimental research 1991;15(3):553-9.
1991: Hermann-Josef Gertz; Lutz G Schmidt
Low melanin content of substantia nigra in a case of neuroleptic malignant syndrome.
Pharmacopsychiatry 1991;24(3):93-5.
1990: Renate Grohmann; Lutz G Schmidt; K Antretter; E Rüther
[Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
Der Internist 1990;31(7):468-74.
1990: Lutz G Schmidt; Hans Rommelspacher
[Biological markers of alcoholism].
Der Nervenarzt 1990;61(3):140-7.
1990: Hans Rommelspacher; H Damm; S Lutter; Lutz G Schmidt; M Otto; N Sachs-Ericsson; G Schmidt
Harman (1-methyl-beta-carboline) in blood plasma and erythrocytes of nonalcoholics following ethanol loading.
Alcohol (Fayetteville, N.Y.) 1990;7(1):27-31.
1990: Renate Grohmann; R Koch; Lutz G Schmidt
Extrapyramidal symptoms in neuroleptic recipients.
Agents and actions. Supplements 1990;29():71-82.
1989: B Wolf; Renate Grohmann; Lutz G Schmidt; Eckart Rüther
Psychiatric admissions due to adverse drug reactions.
Comprehensive psychiatry 1989;30(6):534-45.
1989: Lutz G Schmidt
Utilization and safety of fluspirilene in nonpsychotic outpatients.
Pharmacopsychiatry 1989;22(5):188-91.
1989: Lutz G Schmidt; Renate Grohmann; Bruno Müller-Oerlinghausen; M Otto; E Rüther; B Wolf
Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance data.
The British journal of psychiatry : the journal of mental science 1989;154():839-43.
1989: Renate Grohmann; Eckart Rüther; N Sassim; Lutz G Schmidt
Adverse effects of clozapine.
Psychopharmacology 1989;99 Suppl():S101-4.
1989: Renate Grohmann; Lutz G Schmidt; C Spiess-Kiefer; Eckart Rüther
Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMUP program.
Psychopharmacology 1989;99 Suppl():S109-12.
1988: C Spiess-Kiefer; Renate Grohmann; Lutz G Schmidt; Eckart Rüther
Severe and life-threatening adverse reactions to psychotropic drugs.
Pharmacopsychiatry 1988;21(6):290-2.
1988: Lutz G Schmidt; V Lammers; M Stöckel; Bruno Müller-Oerlinghausen
Recent trends in prescribing psychotropic drugs at a psychiatric university hospital (1981-84).
Pharmacopsychiatry 1988;21(3):126-30.
1988: Lutz G Schmidt; M Schlünder; Friedel M Reischies
[Treatment of attention deficit disorders in adulthood using psychostimulants and low-dose neuroleptics--a critical case report].
Psychiatrische Praxis 1988;15(2):62-5.
1987: Lutz G Schmidt; Renate Grohmann; A Strauss; C Spiess-Kiefer; D Lindmeier; B Müller-Oerlinghausen
Epidemiology of toxic delirium due to psychotropic drugs in psychiatric hospitals.
Comprehensive psychiatry 1987;28(3):242-9.
1986: Renate Grohmann; P Dirschedl; J Scherer; Lutz G Schmidt; O Wunderlich
Reliability of adverse drug reaction assessment in psychiatric inpatients.
Drug information journal 1986;20(3):357-61.
1986: Lutz G Schmidt; P Dirschedl; Renate Grohmann; J Scherer; O Wunderlich; Bruno Müller-Oerlinghausen
Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.
European journal of clinical pharmacology 1986;30(2):199-204.
1986: Lutz G Schmidt; Renate Grohmann; B Müller-Oerlinghausen; H Ochsenfahrt; P S Schönhöfer
Adverse drug reactions to first- and second-generation antidepressants: a critical evaluation of drug surveillance data.
The British journal of psychiatry : the journal of mental science 1986;148():38-43.
1984: Lutz G Schmidt; Renate Grohmann; H Helmchen; K Langscheid-Schmidt; Bruno Müller-Oerlinghausen; W Poser; Eckart Rüther; J Scherer; A Strauss; B Wolf
Adverse drug reactions. An epidemiological study at psychiatric hospitals.
Acta psychiatrica Scandinavica 1984;70(1):77-89.
1984: Renate Grohmann; H Hippius; Bruno Müller-Oerlinghausen; Eckart Rüther; J Scherer; Lutz G Schmidt; A Strauss; B Wolf
Assessment of adverse drug reactions in psychiatric hospitals.
European journal of clinical pharmacology 1984;26(6):727-34.